Cargando…

Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia

Fibroblast growth factor 23 (FGF23) is a hormone that is produced by osteocytes and regulates phosphate and vitamin D metabolism through binding to the Klotho-FGF receptor complex. Excessive actions of FGF23 cause several kinds of hypophosphatemic rickets/osteomalacia. Tumor-induced rickets/osteomal...

Descripción completa

Detalles Bibliográficos
Autor principal:	Fukumoto, Seiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091491/ https://www.ncbi.nlm.nih.gov/pubmed/25031885 http://dx.doi.org/10.3803/EnM.2014.29.2.136

Ejemplares similares

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)
por: Kinoshita, Yuka, et al.
Publicado: (2018)

Selective blood sampling for FGF-23 in tumor-induced osteomalacia
por: Schober, Hans-Christof, et al.
Publicado: (2017)

Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption
por: Hidaka, Naoko, et al.
Publicado: (2021)

A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
por: Nandam, Neeharika, et al.
Publicado: (2020)

Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria
por: Velazquez-Navarro, Jassel A, et al.
Publicado: (2022)

Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer
por: Abramson, Matthew, et al.
Publicado: (2021)

SAT-385 A Normal FGF23 Does Not Preclude Tumor Induced Osteomalacia (TIO)
por: Nandam, Neeharika, et al.
Publicado: (2020)

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
por: Hartley, Iris R., et al.
Publicado: (2022)

Tumor-induced Osteomalacia Caused by a Parotid Tumor
por: Takashi, Yuichi, et al.
Publicado: (2017)

MON-502 It's Not Always Osteoporosis: FGF-23 Induced Osteomalacia
por: Bello Segura, Manuel, et al.
Publicado: (2019)

Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
por: Hautmann, Anke H., et al.
Publicado: (2014)

Diagnostic Dilemma of Elevated FGF23 in a Patient With Osteomalacia: A Case Report
por: Bulut, Aysegul, et al.
Publicado: (2021)

Scintigraphic Findings in FGF23-related Hypophosphatemic Osteomalacia
por: Fujita, Naoya, et al.
Publicado: (2023)

Tumor-induced osteomalacia
por: Yin, Zinan, et al.
Publicado: (2018)

FGF23 Producing Mesenchymal Tumor
por: Papierska, Lucyna, et al.
Publicado: (2014)

SUN-364 Enthesophytes Are a Common Feature of FGF23-Mediated Hypophosphatemia Due to Tumor-Induced Osteomalacia
por: Gafni, Rachel Ilana, et al.
Publicado: (2020)

Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases
por: Bosman, Ariadne, et al.
Publicado: (2022)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia
por: Jan de Beur, Suzanne M., et al.
Publicado: (2022)

A Case of Acute Prosthesis Migration after Femoral Head Replacement due to Osteomalacia by FGF23-Induced Tumor
por: Hayashi, Shinya, et al.
Publicado: (2012)

Tumor-induced osteomalacia
por: Florenzano, Pablo, et al.
Publicado: (2017)

Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia
por: Amarnani, Raj, et al.
Publicado: (2020)

Lessons learnt from delayed diagnosis of FGF-23-producing tumour-induced osteomalacia and post-operative hungry bone syndrome
por: Kumar, S., et al.
Publicado: (2020)

FGF-23 transmitted tumor – induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature
por: Frank, Florian A., et al.
Publicado: (2022)

A case report of mesenchymal scapular FGF secreting tumor: Importance of follow up in tumor induced osteomalacia
por: Shrivastava, Trilok, et al.
Publicado: (2021)

Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level
por: Amblee, Ambika, et al.
Publicado: (2014)

Fibroblast Growth Factor 23-Producing Phosphaturic Mesenchymal Tumor with Extraordinary Morphology Causing Oncogenic Osteomalacia
por: Then, Cornelia, et al.
Publicado: (2020)

Burden of Disease in Patients With Tumor‐Induced Osteomalacia
por: Jerkovich, Fernando, et al.
Publicado: (2020)

A Case of Tumor-Induced Osteomalacia Detected by Venous Sampling
por: Horinouchi, Yasuo, et al.
Publicado: (2023)

Treating ‘osteoporosis’: a near miss in an unusual case of FGF-23-mediated hypophosphataemic osteomalacia
por: Lin, Mike, et al.
Publicado: (2022)

Epidemiology of Tumor-Induced Osteomalacia in Denmark
por: Abrahamsen, Bo, et al.
Publicado: (2021)

Burosumab for the Treatment of Tumor‐Induced Osteomalacia
por: Jan de Beur, Suzanne M, et al.
Publicado: (2021)

Tumor-induced osteomalacia treated with T12 tumor resection
por: Mancini, Alyssa J, et al.
Publicado: (2022)

Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt
por: Seemann, LaRae, et al.
Publicado: (2019)

Bone scintigraphic patterns in patients of tumor induced osteomalacia
por: Sood, Ashwani, et al.
Publicado: (2013)

Perioperative concerns in patients with tumor-induced osteomalacia for surgical excision of tumor
por: Pandey, Ravindra, et al.
Publicado: (2012)

Consensus on clinical management of tumor-induced osteomalacia
por: Jiang, Yan, et al.
Publicado: (2021)

Tumor-induced osteomalacia: a case report
por: Aligail, Khalid, et al.
Publicado: (2022)

Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia
por: Imanishi, Yasuo, et al.
Publicado: (2020)

Multiple Looser zones of osteomalacia in Byler disease with associated vitamin D deficiency, phosphaturia, and elevated FGF23
por: Tarazi, M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nrpeci78ueo1i29iek3m1di72g